As of 2025-12-15, the Relative Valuation of Adverum Biotechnologies Inc (ADVM) is (49.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.36 USD, the upside of Adverum Biotechnologies Inc based on Relative Valuation is -1227.2%.
The range of the Relative Valuation is (37.55) - (60.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 15.1x | 12.2x |
| Forward P/E multiples | 9.4x - 15.2x | 12.3x |
| Fair Price | (37.55) - (60.50) | (49.15) |
| Upside | -961.3% - -1487.6% | -1227.2% |
| Date | P/E |
| 2025-12-08 | -1.09 |
| 2025-12-05 | -1.06 |
| 2025-12-04 | -1.04 |
| 2025-12-03 | -1.04 |
| 2025-12-02 | -1.04 |
| 2025-12-01 | -1.05 |
| 2025-11-28 | -1.03 |
| 2025-11-26 | -1.04 |
| 2025-11-25 | -1.02 |
| 2025-11-24 | -1.03 |
| 2025-11-21 | -1.03 |
| 2025-11-20 | -1.04 |
| 2025-11-19 | -1.06 |
| 2025-11-18 | -1.06 |
| 2025-11-17 | -1.06 |
| 2025-11-14 | -1.07 |
| 2025-11-13 | -1.06 |
| 2025-11-12 | -1.07 |
| 2025-11-11 | -1.08 |
| 2025-11-10 | -1.07 |
| 2025-11-07 | -1.08 |
| 2025-11-06 | -1.07 |
| 2025-11-05 | -1.07 |
| 2025-11-04 | -1.08 |
| 2025-11-03 | -1.07 |
| 2025-10-31 | -1.07 |
| 2025-10-30 | -1.05 |
| 2025-10-29 | -1.05 |
| 2025-10-28 | -1.06 |
| 2025-10-27 | -1.06 |
| 2025-10-24 | -1.01 |
| 2025-10-23 | -1.04 |
| 2025-10-22 | -1.06 |
| 2025-10-21 | -1.11 |
| 2025-10-20 | -1.11 |
| 2025-10-17 | -1.07 |
| 2025-10-16 | -1.14 |
| 2025-10-15 | -1.12 |
| 2025-10-14 | -1.14 |
| 2025-10-13 | -1.04 |
| 2025-10-10 | -1.20 |
| 2025-10-09 | -1.33 |
| 2025-10-08 | -1.22 |
| 2025-10-07 | -1.23 |
| 2025-10-06 | -1.32 |
| 2025-10-03 | -1.34 |
| 2025-10-02 | -1.31 |
| 2025-10-01 | -1.25 |
| 2025-09-30 | -1.13 |
| 2025-09-29 | -1.15 |